Condition
Infertility (IVF Patients) clinical trials and research
As of November 12, 2026, Find a Trial lists 23 Infertility (IVF Patients) clinical trials that are recruiting, at sites in 12 countries (most in United States (9), Spain (3), Vietnam (2)). 1 was first registered in the last 30 days. By phase: Phase 4 (2), Phase 3 (1), Phase 2/3 (1), Phase 1/2 (1). The most active sponsors are Reproductive Medicine Associates of New Jersey (3), Igenomix (2), University of Iowa (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 23Clinical trials
- 1New in 30 days
- 12Countries
Newest Infertility (IVF Patients) clinical trials
All recruiting trials (23)
-
Differential Granulosa Cell Transcriptome Profiling to Predict Ongoing Pregnancy
Aiming to see if differences in granulosa cell gene activity can predict ongoing pregnancy in IVF and oocyte donation with PGT-A.
-
Detoxify for IVF: Cutting Everyday Pollutants to Help Infertility
This study tests a guide to help IVF patients reduce everyday environmental pollutants and sees if it lowers chemical exposure in urine, blood, and follicular fluid.
-
Carnitine and related supplements before IVF to see if they improve oocytes and embryos
This trial tests whether taking a supplement mix that includes L-carnitine before IVF helps improve the number and quality of eggs and embryos and the chances of pregnancy for women undergoing IVF.
-
Higher or lower starting FSH dose for good-prognosis IVF with PPOS
This trial tests whether starting IVF stimulation with 225 IU or 300 IU of FSH improves oocyte and embryo outcomes in good-prognosis women using PPOS.
-
Environmental and lifestyle factors linked to ART success in infertility patients
This study follows 5,000 infertile men and women to see how environmental exposures and lifestyle relate to the success of assisted reproductive technology.
-
AI tool to analyze sperm and predict their ability to help IVF/ICSI succeed
This project will test an AI platform that analyzes semen samples from men providing sperm for IVF/ICSI to see if it can predict which samples have the best chance of supporting successful IVF/ICSI outcomes.
-
Multiomics study of discarded fresh blastocysts to see patterns linked to chromosomal status
This study tests whether multiomics patterns in discarded 5–6 day blastocysts relate to chromosomal status to better predict embryo viability for IVF patients.
-
Comparing IVF outcomes and embryo development between PPOS and GnRH antagonist protocols using time-lapse culture
This trial tests whether a fixed progestin-primed ovarian stimulation (PPOS) protocol produces similar numbers of mature eggs, good-quality embryos, and clinical outcomes — and whether embryo development patterns differ — compared with a GnRH antagonist protocol in women undergoing IVF with a planned freeze-all strateg
-
Integrative care guided by biological aging markers for unexplained female infertility
This trial tests whether measuring telomeres and other biological aging markers can guide a personalized integrative treatment to help women aged 25–42 with persistent unexplained infertility improve their chances of pregnancy.
-
Standardizing embryo transfer steps for frozen embryo transfers
This trial tests whether using specialized transfer devices to keep embryos warm and deliver them with precise, controlled motion can increase pregnancy success for people having frozen embryo transfer after IVF/ICSI.
-
Growth hormone versus DHEA to boost follicle response in IVF for poor ovarian responders
This trial will test whether adding growth hormone or DHEA helps women with poor ovarian reserve produce more and larger follicles during ICSI.
-
Giving ketorolac for pain after egg retrieval in fresh embryo transfer IVF cycles
This trial tests whether a single IV dose of ketorolac given after egg retrieval helps control pain for people planning a day-5 fresh embryo transfer without lowering their chances of pregnancy.
-
Personalized IVF medication planning using the Opt‑IVF decision tool
This trial will test whether a computer tool called Opt‑IVF can choose better, personalized ovarian stimulation drug doses for women having IVF than the current standard dosing.
-
AI-driven support to improve patient engagement during IVF
This project will test whether an AI tool that provides personalized live-birth probabilities and tailored messages helps people aged 18–45 undergoing IVF/ICSI or donor cycles stay engaged with treatment and follow clinic recommendations.
-
Using hCG to trigger a corpus luteum before a thawed embryo transfer
This trial will test whether giving a single hCG injection to create a corpus luteum helps people have better success with a thawed embryo transfer.
-
Using Rekovelle (follitropin delta) with a long GnRH‑agonist protocol for IVF/ICSI
This study tries individualized dosing of follitropin delta (Rekovelle) based on weight and AMH for women undergoing IVF or ICSI with a long GnRH‑agonist protocol.
-
Abnormally Fertilized Embryos: Does Chromosomal Content Stay Balanced in IVF
This study tests whether embryos from abnormal fertilization can still have the right number of chromosomes and be usable in IVF for couples with limited viable embryos.
-
Biobank for male infertility specimens
This study is collecting leftover sperm and tissue samples from men who have had fertility treatments to help improve understanding and treatment of male infertility in the future.
-
Measuring Uterine Elasticity in Women During Their Menstrual Cycle
This study is testing how stretchy the uterus and ovaries are at different times during the menstrual cycle to see if this information can help women with fertility treatments.
-
Day‑3 (cleavage) versus day‑5–7 (blastocyst) embryo transfer for IVF patients with few embryos
This test compares whether transferring embryos on day 3 (8‑cell cleavage stage) or waiting until day 5–7 (blastocyst) leads to better pregnancy and live birth outcomes for people having their first IVF cycle who produce five or fewer embryos.
-
Using AI to predict uterine lining receptivity during IVF
This project will try using artificial intelligence to read routine vaginal ultrasound images of the uterine lining to see if it can predict implantation success for people aged 18–40 undergoing IVF with a single blastocyst transfer.
-
Exploring how language affects fertility treatment progress
This study is testing whether Spanish-speaking patients have a better experience and faster progress in fertility treatments when they communicate with a Spanish-speaking provider instead of using an interpreter.
-
Exploring how paternal age affects sperm selection in IVF
This study tests if using a new sperm selection device helps men of different ages have better success with IVF compared to the traditional method.
Related topics
Quick answers
How many Infertility (IVF Patients) clinical trials are recruiting right now?
23, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in United States (9 trials), Spain (3 trials), Vietnam (2 trials), Portugal (1 trial), Norway (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2, Phase 3: 1, Phase 2/3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.